What will you do if you get COVID while waiting in line for the vaccine, or even after?
If you are in Mexico City, you will be treated with ivermectin. As of Dec 29, this long-established drug has been used in COVID-positive patients, and soon thereafter death rates started to plummet, as the graphic shows. By Jan 22, about 50,000 doses had been delivered.
Mexico City is following the example of the state of Chiapas, which saw cases drop by two-thirds after it started using ivermectin on Aug 1, as Dr. Pierre Kory told the U.S. Senate Committee on Homeland Security and Governmental Affairs on Dec 8.
It is too soon to see whether vaccinations decrease the rate of COVID hospitalizations or deaths. In the U.S., these are still rising, and the official policy on early treatment is still therapeutic nihilism. The National Institutes of Health (NIH) did update its long-standing recommendation against ivermectin to “neutral.” It considers the evidence from 39 trials, all favorable, to be insufficient.
We are already seeing adverse side effects from the vaccine. Some 151 deaths shortly following (but not necessarily caused by) the vaccine have been reported to the Vaccine Adverse Events Reporting System (VAERS). A nurse who cares for nursing home residents describes deterioration in his patients’ mobility and cognition after their second dose.
Between Dec 14 and Dec 18, about 272,001 doses of the Pfizer/BioNTech vaccine were administered and 3,150 “Health Impact Events” were recorded (1.1%). The CDC’s definition of Health Impact Events is “unable to perform normal daily activities, unable to work, required care from doctor or health care professional.” It is not known how serious or long-lasting the events were. When people receive the vaccine, they will receive information on signing up for the V-safe program.
It is not known whether the vaccine would prevent or ameliorate the disease if taken after exposure. It is also not known whether vaccinated persons can transmit disease, according to the Robert Koch Institute. Vaccinated persons can be treated if they get COVID.
Head-to-head comparisons between long-term results of early treatment versus vaccination are not being done.
For some vulnerable populations, such as prison inmates, it is too late for vaccination. In one Arizona prison, more than half the inmates tested positive for COVID-19 in early December. AAPS has a asked Arizona governor Doug Ducey to facilitate making ivermectin available in prisons and other high-risk settings.
For further information, see: